Oncotelic Therapeutics Inc
OTC:OTLC
Oncotelic Therapeutics Inc
OTC:OTLC
Price:
0.037 USD
Market Closed
Updated:
Jun 6, 2024
Oncotelic Therapeutics Inc
Common Shares Outstanding
|
Oncotelic Therapeutics Inc
Common Shares Outstanding Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Oncotelic Therapeutics Inc
OTC:OTLC
|
Common Shares Outstanding
$399.2m
|
CAGR 3-Years
64%
|
CAGR 5-Years
57%
|
CAGR 10-Years
53%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Common Shares Outstanding
$1.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Common Shares Outstanding
$1.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Common Shares Outstanding
$536.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Common Shares Outstanding
$258.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Common Shares Outstanding
$110.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Oncotelic Therapeutics Inc's Common Shares Outstanding?
Common Shares Outstanding
399.2m
USD
399.2m
USD
Based on the financial report for Dec 31, 2023, Oncotelic Therapeutics Inc's Common Shares Outstanding amounts to 399.2m USD.
What is Oncotelic Therapeutics Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
53%
53%
Over the last year, the Common Shares Outstanding growth was 2%. The average annual Common Shares Outstanding growth rates for Oncotelic Therapeutics Inc have been 64% over the past three years , 57% over the past five years , and 53% over the past ten years .
You don't have any saved screeners yet
